Skip to main content
Have a personal or library account? Click to login
A Novel 4.2 kb deletion of the 3′UTR of RUNX2 Gene Causes Cleidocranial Dysplasia: Further Delineation of the Role of yhe 3′UTR Cover

A Novel 4.2 kb deletion of the 3′UTR of RUNX2 Gene Causes Cleidocranial Dysplasia: Further Delineation of the Role of yhe 3′UTR

Open Access
|May 2026

References

  1. Feldman GJ, Robin NH, Brueton LA, Robertson E, Thompson EM, Siegel-Bartelt J, et al. A gene for cleidocranial dysplasia maps to the short arm of chromosome 6. Am J Hum Genet. 1995;56(4):938–43.
  2. Mundlos S. Cleidocranial dysplasia: Clinical and molecular genetics. J Med Genet. 1999;36(3):177–82.
  3. Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, et al. Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A. 2023;191(5):1164–1209.
  4. Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javed A, et al. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene. 2004;24;23(24):4315–29.
  5. Vimalraj S, Arumugam B, Miranda PJ, Selvamurugan N. Runx2: Structure, function, and phosphorylation in osteoblast differentiation. Int J Biol Macromol. 2015:78:202–8.
  6. Komori T. Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem Cell Biol. 2018;149(4):313–323.
  7. Motaei J, Salmaninejad A, Jamali E, Khorsand I, Ahmadvand M, Shabani S, et al. Molecular Genetics of Cleidocranial Dysplasia. Fetal Pediatr Pathol. 2021;40(5):442–54.
  8. Dalle Carbonare L, Minoia A, Gandini A, Piritore FC, Patuzzo C, Ceretti L, et al. Unraveling RUNX2 mutation in a cleidocranial dysplasia patient: Molecular insights into osteogenesis and proteostasis. Genes Dis. 2024;6;12(4):101449.
  9. Machol K, Mendoza-Londono R, Lee B. Cleidocranial Dysplasia Spectrum Disorder. In: GeneReviews® (Internet). Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. Seattle (WA): University of Washington, Seattle; 1993–2025 (updated 2023 Apr 13).
  10. Jaruga A, Hordyjewska E, Kandzierski G, Tylzanowski P. Cleidocranial dysplasia and RUNX2-clinical phenotype-genotype correlation. Clin Genet. 2016;90(5):393–402.
  11. Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, Ito Y, et al. Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet. 2002;71(4):724–38.
  12. Thaweesapphithak S, Termteerapornpimol K, Wong-sirisuwan S, Chantarangsu S, Porntaveetus T. The impact of RUNX2 gene variants on cleidocranial dysplasia phenotype: a systematic review. J Transl Med. 2024;3;22(1):1099.
  13. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
  14. Zhang J, Li YZ, Chen WQ, Yuan JY, Li Q, Meng YX, et al. Genome sequencing identified a novel exonic microdeletion in the RUNX2 gene that causes cleidocranial dysplasia. Clin Chim Acta. 2022;528(1):6–12.
  15. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22(2):245–257.
  16. Ott CE, Leschik G, Trotier F, Brueton L, Brunner HG, Brussel W, et al. Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum Mutat. 2010;31(8):1587–93.
  17. Zhang Y, Duan X. A Novel 90-kbp Deletion of RUNX2 Associated with Cleidocranial Dysplasia. Genes (Basel). 2022;23;13(7):1128.
  18. Puvabanditsin S, February M, Mayne J, McConnell J, Meht R. Cleidocranial dysplasia with 6p21.1–p12.3 microdeletion: A case report and literature review. Cleft Palate-Craniofacial J. 2018;55(6):891–4.
  19. Lee MT, Tsai AC, Chou CH, Sun FM, Huang LC, Yen P, et al. Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia. Genomic Med. 2008 Jan;2(1–2):45–9.
  20. Bedeschi MF, Bonarrigo F, Manzoni F, Milani D, Piemontese MR, Guez S, et al. Ehlers-Danlos syndrome versus cleidocranial dysplasia. Ital J Pediatr. 2014 May 24:40:49.
  21. Chen T, Hou J, Hu LL, Gao J, Wu BL. A novel small deletion mutation in RUNX2 gene in one Chinese family with cleidocranial dysplasia. Int J Clin Exp Pathol. 2014;15;7(5):2490–5.
  22. Chen M, Lin SM, Li N, Li Y, Li Y, Zhang L. An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia. Stem Cell Res. 2021 Mar 51:102166.
  23. Zhang W, Wu Y, Shiozaki Y, Sugimoto Y, Takigawa T, Tanaka M, et al. MiRNA-133a-5p inhibits the expression of osteoblast differentiation-associated markers by targeting the 3′ UTR of RUNX2. DNA Cell Biol. 2018;37(3):199–209.
  24. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, Van Wijnen AJ, et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A. 2011;108(24):9863–8.
  25. Moriano J, Martínez-Gil N, Andirkó A, Balcells S, Grinberg D, Boeckx C. Human-derived alleles in SOST and RUNX2 3 UTRs cause 1 differential regulation in a bone cell-line model 2. bioRxiv. 2021;2021.04.21.440797.
  26. Stavropoulos DJ, Merico D, Jobling R, Bowdin S, Monfared N, Thiruvahindrapuram B, et al. Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine. NPJ Genom Med. 2016 Jan 13:1:15012.
Language: English
Page range: 107 - 112
Published on: May 14, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 M Mijovic, G Cuturilo, J Ruml Stojanovic, M Brankovic, A Miletic, B Bosankic, M Dedovic, D Perovic, N Maksimovic, T Damnjanovic, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.